417 related articles for article (PubMed ID: 25528406)
21. Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway.
Yoshimura N; Kuno S; Chancellor MB; De Groat WC; Seki S
Br J Pharmacol; 2003 Aug; 139(8):1425-32. PubMed ID: 12922929
[TBL] [Abstract][Full Text] [Related]
22. Naringin treatment induces neuroprotective effects in a mouse model of Parkinson's disease in vivo, but not enough to restore the lesioned dopaminergic system.
Kim HD; Jeong KH; Jung UJ; Kim SR
J Nutr Biochem; 2016 Feb; 28():140-6. PubMed ID: 26878791
[TBL] [Abstract][Full Text] [Related]
23. Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions.
Chen L; Liu J; Ali U; Gui ZH; Hou C; Fan LL; Wang Y; Wang T
Brain Res Bull; 2011 Feb; 84(3):215-23. PubMed ID: 21255635
[TBL] [Abstract][Full Text] [Related]
24. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
25. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
Aponso PM; Faull RL; Connor B
Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
[TBL] [Abstract][Full Text] [Related]
26. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
27. Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model.
Sampaio TB; Pinton S; da Rocha JT; Gai BM; Nogueira CW
Eur J Pharmacol; 2017 Jan; 795():28-35. PubMed ID: 27915043
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease.
Crotty S; Fitzgerald P; Tuohy E; Harris DM; Fisher A; Mandel A; Bolton AE; Sullivan AM; Nolan Y
Eur J Neurosci; 2008 Jan; 27(2):294-300. PubMed ID: 18190522
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
[TBL] [Abstract][Full Text] [Related]
31. Preventive Effect of Two New Neurotensin Analogues on Parkinson's Disease Rat Model.
Lazarova M; Popatanasov A; Klissurov R; Stoeva S; Pajpanova T; Kalfin R; Tancheva L
J Mol Neurosci; 2018 Dec; 66(4):552-560. PubMed ID: 30374780
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease.
Morroni F; Tarozzi A; Sita G; Bolondi C; Zolezzi Moraga JM; Cantelli-Forti G; Hrelia P
Neurotoxicology; 2013 May; 36():63-71. PubMed ID: 23518299
[TBL] [Abstract][Full Text] [Related]
33. Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease.
González S; Scorticati C; García-Arencibia M; de Miguel R; Ramos JA; Fernández-Ruiz J
Brain Res; 2006 Feb; 1073-1074():209-19. PubMed ID: 16412990
[TBL] [Abstract][Full Text] [Related]
34. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
[TBL] [Abstract][Full Text] [Related]
35. Phloroglucinol attenuates motor functional deficits in an animal model of Parkinson's disease by enhancing Nrf2 activity.
Ryu J; Zhang R; Hong BH; Yang EJ; Kang KA; Choi M; Kim KC; Noh SJ; Kim HS; Lee NH; Hyun JW; Kim HS
PLoS One; 2013; 8(8):e71178. PubMed ID: 23976995
[TBL] [Abstract][Full Text] [Related]
36. Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson's disease: Possible involvement of PI3K/ERβ signaling.
Baluchnejadmojarad T; Jamali-Raeufy N; Zabihnejad S; Rabiee N; Roghani M
Eur J Pharmacol; 2017 Apr; 801():72-78. PubMed ID: 28284752
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective effects of a selective N-methyl-D-aspartate NR2B receptor antagonist in the 6-hydroxydopamine rat model of Parkinson's disease.
Leaver KR; Allbutt HN; Creber NJ; Kassiou M; Henderson JM
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1388-94. PubMed ID: 18785982
[TBL] [Abstract][Full Text] [Related]
38. Ameliorating effects of combined curcumin and desferrioxamine on 6-OHDA-induced rat mode of Parkinson's disease.
Lv H; Liu J; Wang L; Zhang H; Yu S; Li Z; Jiang F; Niu Y; Yuan J; Cui X; Wang W
Cell Biochem Biophys; 2014 Nov; 70(2):1433-8. PubMed ID: 24989681
[TBL] [Abstract][Full Text] [Related]
39. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA
Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinson's Disease.
Sarkaki A; Farbood Y; Dolatshahi M; Mansouri SM; Khodadadi A
Acta Med Iran; 2016 Aug; 54(8):494-502. PubMed ID: 27701719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
